Press releases
- Local budding biologists explore the past, present and future during GSK Science in the Summer™ in partnership with the Franklin Institute
- GSK delivers strong Q1 2022 sales of £9.8 billion, +32% AER, +32% CER; Total EPS 35.9p +67% AER, +66% CER and Adjusted EPS 32.8p +43% AER, +43% CER
- US Food and Drug Administration accepts New Drug Application for daprodustat
Tweets from GSK US
-
GSKUS @GSKUS
More than 100 countries mark the day @WHO removed homosexuality from the disease classification. We asked some of our colleagues what #IDAHOBIT🏳🌈 means to them. Their dedication an#allyshipip allows GSK to unite science, technology and talent kDw
about 8 minutes ago -
GSKUS @GSKUS
Kick off #EosinophilAwarenessWeek learning about eosinophils, a type of white blood cell, which are linked to severe eosinophilic asthma. Learn more about how your eosinophil count could impact your breathing. #Eosinophilosophy #ATS2022
about 6 hours ago -
GSKUS @GSKUS
As we mark #AAPIMonth, we celebrate the many contributions & achievements that emerge from appreciating different histories, cultures & communities. Meet Nivi, a leader at GSK who epitomizes this year’s theme Advancing Leaders Through Collaboration 👇
about 2 days ago
